• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

罗德岛同情中心就诊的医用大麻患者概况。

Profiles of medicinal cannabis patients attending compassion centers in rhode island.

作者信息

Zaller Nickolas, Topletz Ariel, Frater Susan, Yates Gail, Lally Michelle

机构信息

a Associate Professor, University of Arkansas for Medical Sciences-Health Behavior and Health Education , Little Rock , AR.

出版信息

J Psychoactive Drugs. 2015 Jan-Mar;47(1):18-23. doi: 10.1080/02791072.2014.999901.

DOI:10.1080/02791072.2014.999901
PMID:25715068
Abstract

Little is understood regarding medicinal marijuana dispensary users. We sought to characterize socio-demographics and reasons for medicinal marijuana use among medical cannabis dispensary patients in Rhode Island. Participants (n=200) were recruited from one of two Compassion Centers in Rhode Island and asked to participate in a short survey, which included assessment of pain interference using the Brief Pain Inventory (BPI). The majority of participants were male (73%), Caucasian (80%), college educated (68%), and had health insurance (89%). The most common reason for medicinal marijuana use was determined to be chronic pain management. Participants were more likely to have BPI pain interference scores of > 5 if they were older (OR: 1.36, 95% CI: 1.04-1.78) or reported using cannabis as a substitute for prescription medications (OR: 2.47, 95% CI: 1.23-4.95), and were less likely to have interference scores of >5 if they had higher income levels (OR: 0.53, 95% CI: 0.40-0.70) or reported having ever received treatment for an alcohol use disorder. One-fifth of participants had a history of a drug or alcohol use disorder. Most participants report that medicinal cannabis improves their pain symptomology, and are interested in alternative treatment options to opioid-based treatment regimens.

摘要

关于医用大麻药房使用者,人们了解得很少。我们试图描述罗德岛医用大麻药房患者的社会人口统计学特征以及使用医用大麻的原因。参与者(n = 200)从罗德岛的两个同情中心之一招募,并被要求参与一项简短调查,其中包括使用简明疼痛量表(BPI)评估疼痛干扰情况。大多数参与者为男性(73%)、白人(80%)、受过大学教育(68%)且有医疗保险(89%)。使用医用大麻最常见的原因被确定为慢性疼痛管理。如果参与者年龄较大(比值比:1.36,95%置信区间:1.04 - 1.78)或报告使用大麻替代处方药(比值比:2.47,95%置信区间:1.23 - 4.95),他们的BPI疼痛干扰得分更有可能大于5;如果收入水平较高(比值比:0.53,95%置信区间:0.40 - 0.70)或报告曾接受过酒精使用障碍治疗,则干扰得分大于5的可能性较小。五分之一的参与者有药物或酒精使用障碍史。大多数参与者报告称医用大麻改善了他们的疼痛症状,并且对基于阿片类药物的治疗方案的替代治疗选择感兴趣。

相似文献

1
Profiles of medicinal cannabis patients attending compassion centers in rhode island.罗德岛同情中心就诊的医用大麻患者概况。
J Psychoactive Drugs. 2015 Jan-Mar;47(1):18-23. doi: 10.1080/02791072.2014.999901.
2
Cannabis Use and Risk of Prescription Opioid Use Disorder in the United States.美国大麻使用与处方阿片类药物使用障碍风险
Am J Psychiatry. 2018 Jan 1;175(1):47-53. doi: 10.1176/appi.ajp.2017.17040413. Epub 2017 Sep 26.
3
Pills to Pot: Observational Analyses of Cannabis Substitution Among Medical Cannabis Users With Chronic Pain.从药丸到大麻:慢性疼痛患者医用大麻使用者中大麻替代物的观察性分析。
J Pain. 2019 Jul;20(7):830-841. doi: 10.1016/j.jpain.2019.01.010. Epub 2019 Jan 26.
4
Characteristics of substance use disorder treatment patients using medical cannabis for pain.使用医用大麻治疗疼痛的物质使用障碍治疗患者的特征。
Addict Behav. 2015 Mar;42:185-8. doi: 10.1016/j.addbeh.2014.11.024. Epub 2014 Nov 26.
5
Patterns and correlates of medical cannabis use for pain among patients prescribed long-term opioid therapy.长期阿片类药物治疗患者中用于疼痛的医用大麻使用模式和相关因素。
Gen Hosp Psychiatry. 2018 Jan-Feb;50:104-110. doi: 10.1016/j.genhosppsych.2017.11.001. Epub 2017 Nov 8.
6
New Zealand Health Survey 2012/13: characteristics of medicinal cannabis users.《2012/13年新西兰健康调查:药用大麻使用者的特征》
N Z Med J. 2016 Apr 22;129(1433):25-36.
7
The Effect of Medicinal Cannabis on Pain and Quality-of-Life Outcomes in Chronic Pain: A Prospective Open-label Study.药用大麻对慢性疼痛患者疼痛及生活质量的影响:一项前瞻性开放标签研究。
Clin J Pain. 2016 Dec;32(12):1036-1043. doi: 10.1097/AJP.0000000000000364.
8
Effect of Inhaled Cannabis for Pain in Adults With Sickle Cell Disease: A Randomized Clinical Trial.吸入大麻治疗镰状细胞病成人疼痛的效果:一项随机临床试验。
JAMA Netw Open. 2020 Jul 1;3(7):e2010874. doi: 10.1001/jamanetworkopen.2020.10874.
9
Self-reported Medicinal Cannabis Use as an Alternative to Prescription and Over-the-counter Medication Use Among US Military Veterans.美国退伍军人中自我报告使用药用大麻替代处方药和非处方药的情况。
Clin Ther. 2023 Jun;45(6):562-577. doi: 10.1016/j.clinthera.2023.04.003.
10
Use of prescription pain medications among medical cannabis patients: comparisons of pain levels, functioning, and patterns of alcohol and other drug use.医用大麻患者中处方止痛药的使用:疼痛程度、功能以及酒精和其他药物使用模式的比较。
J Stud Alcohol Drugs. 2015 May;76(3):406-13. doi: 10.15288/jsad.2015.76.406.

引用本文的文献

1
The evolving culture of medical cannabis in Canada for the management of chronic pain.加拿大医用大麻用于慢性疼痛管理的文化演变。
Front Pharmacol. 2023 Apr 7;14:1153584. doi: 10.3389/fphar.2023.1153584. eCollection 2023.
2
Survey of Patients Employing Cannabigerol-Predominant Cannabis Preparations: Perceived Medical Effects, Adverse Events, and Withdrawal Symptoms.大麻素二酚优势型大麻制剂患者调查:感知的医疗效果、不良事件和戒断症状。
Cannabis Cannabinoid Res. 2022 Oct;7(5):706-716. doi: 10.1089/can.2021.0058. Epub 2021 Sep 27.
3
Cannabis against chronic musculoskeletal pain: a scoping review on users and their perceptions.
大麻与慢性肌肉骨骼疼痛:关于使用者及其认知的范围综述
J Cannabis Res. 2021 Sep 4;3(1):41. doi: 10.1186/s42238-021-00096-8.
4
Opioid-sparing effects of medical cannabis or cannabinoids for chronic pain: a systematic review and meta-analysis of randomised and observational studies.医用大麻或大麻素治疗慢性疼痛的阿片类药物节约效应:随机和观察性研究的系统评价和荟萃分析。
BMJ Open. 2021 Jul 28;11(7):e047717. doi: 10.1136/bmjopen-2020-047717.
5
Medical cannabis use in the United States: a retrospective database study.美国医用大麻的使用:一项回顾性数据库研究。
J Cannabis Res. 2020 Sep 29;2(1):32. doi: 10.1186/s42238-020-00038-w.
6
Cannabis use and patterns among middle and older aged Canadians prior to legalization: a sex-specific analysis of the Canadian Tobacco, Alcohol and Drugs Survey.在大麻合法化之前加拿大中老年人群的使用情况和模式:基于加拿大烟草、酒精和毒品调查的性别特异性分析。
BMC Public Health. 2021 Jan 6;21(1):26. doi: 10.1186/s12889-020-10074-z.
7
Medical Marijuana and Opioids (MEMO) Study: protocol of a longitudinal cohort study to examine if medical cannabis reduces opioid use among adults with chronic pain.医用大麻与阿片类药物(MEMO)研究:一项纵向队列研究方案,旨在观察医用大麻是否能减少慢性疼痛成年患者的阿片类药物使用量。
BMJ Open. 2020 Dec 29;10(12):e043400. doi: 10.1136/bmjopen-2020-043400.
8
Sex differences in driving under the influence of cannabis: The role of medical and recreational cannabis use.大麻影响下驾驶的性别差异:医用大麻和娱乐用大麻使用的作用。
Addict Behav. 2020 Nov;110:106525. doi: 10.1016/j.addbeh.2020.106525. Epub 2020 Jun 26.
9
Medical Cannabis Use by Rheumatology Patients Following Recreational Legalization: A Prospective Observational Study of 1000 Patients in Canada.娱乐用大麻合法化后风湿病患者使用医用大麻的情况:对加拿大1000名患者的前瞻性观察研究。
ACR Open Rheumatol. 2020 May;2(5):286-293. doi: 10.1002/acr2.11138. Epub 2020 Apr 30.
10
Is marijuana use associated with decreased use of prescription opioids? Toxicological findings from two US national samples of drivers.大麻使用是否与处方类阿片类药物使用减少有关?来自两个美国全国驾驶员样本的毒理学发现。
Subst Abuse Treat Prev Policy. 2020 Feb 17;15(1):12. doi: 10.1186/s13011-020-00257-7.